Skip to main content

Germany on the forefront of pushing open-access academic publishing










BERLIN—In a third-floor conference room here overlooking the famous Potsdamer Platz, once bisected by the Berlin Wall, the future of academic publishing is being negotiated. The backdrop is fitting, because if the librarians and academic leaders at the table get their way, another major divide will soon fall: the paywall that surrounds most research papers.
Over the past 2 years, more than 150 German libraries, universities, and research institutes have formed a united front trying to force academic publishers into a new way of doing business. Instead of buying subscriptions to specific journals, consortium members want to pay publishers an annual lump sum that covers publication costs of all papers whose first authors are at German institutions. Those papers would be freely available around the world; meanwhile, German institutions would receive access to all the publishers' online content.
Consortia of libraries and universities in the Netherlands, Finland, Austria, and the United Kingdom have all pushed for similar agreements, but have had to settle for less than they wanted. In the Netherlands, for example, Elsevier—the world's biggest academic publisher—has agreed to make only 30% of Dutch-authored papers freely available by 2018, and only after a significant increase in the annual sum libraries pay

Comments

  1. Anonymous9/15/2017

    Good Germany is taking leads, I hope other countries will follow suit

    ReplyDelete
  2. Harrah's Atlantic City - Mapyro
    Find 울산광역 출장마사지 out what's popular at Harrah's Atlantic City in realtime and see activity. The map shows activity 영천 출장샵 with a grid layout. Harrah's Atlantic 수원 출장마사지 City Hotel & 구리 출장안마 Casino Atlantic 여주 출장샵 City.

    ReplyDelete

Post a Comment

Popular posts from this blog

Covid-19 treatment: Algeria to continue using Hydroxychloroquine

Algerian authorities have vowed they will not give up on the controversial use of hydroxychloroquine in the treatment against coronavirus, despite the decision of the World Health Organization ( WHO ) to suspend clinical trials, a member of the Pandemic Monitoring Committee said Tuesday. “We have treated thousands of cases with this drug with great success to date. And we have not noted any adverse reactions,” Dr. Mohamed Bekkat, a member of the Scientific Committee monitoring the evolution of the Covid-19 pandemic in Algeria, told AFP . “We have not recorded any deaths related to the use of (hydroxy)chloroquine,” said Dr. Bekkat, also president of the Council of the Algerian Medical Association. READ MORE

On Africa Day, Ramaphosa praises the continent for its ‘swiftness’ in battling Covid-19

The African response to the coronavirus pandemic has received widespread praise. Despite the multitude of resource challenges they face, African countries have come together in remarkable ways, united by a common purpose. The countries of the Global South are more vulnerable to the impacts of COVID-19 because of low levels of development, insufficient resources and weak health systems. READ MORE